Constantly rising incidence of infectious diseases to drive global virology and bacteriology market
According to TechSci Research report, “Global Virology and Bacteriology Market By Technology, By Disease, By End User, By Region, Competition, Forecast & Opportunities, 2025”, the global virology and bacteriology market is project to witness a CAGR of 12% during 2021- 2025, majorly on account of continuously growing cases of infectious diseases worldwide coupled with advances in molecular diagnostic technologies. Also, continuing spread of AIDS and rising threat of bioterrorism is making headway for the growth of global virology and bacteriology market across the globe. Along with this, supportive government funding, reimbursement policies and increasing investments by public and private bodies is expected to fuel the market growth during the next five years. However, there are some factors that can act as major impediments to the growth of global virology and bacteriology market through 2025 such as concerns pertaining to reimbursement policies and regulatory scenarios in various countries.
Browse 152 market data Figures spread through 120 Pages and an in-depth TOC on “ Global Virology and Bacteriology Market “
Global virology and bacteriology market can be segmented based on technology, disease, end user, and region. Considering the end user segmentation, the market is fragmented into clinics, hospitals, diagnostic centers, research laboratories, and blood banks. The research laboratories segment dominated the global virology and bacteriology market until 2019 and is further anticipated to maintain its dominance during the forecast period as well. In term of disease, the market is segregated into respiratory system, urinary tract, and bloodstream diseases; gastrointestinal and periodontal diseases; sexually transmitted diseases. Respiratory system segment accounted for largest market share in 2019 and is further anticipated to grow at a high pace over the next five years on account of increase in population suffering from respiratory disorders.
Download sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=4700 customers can also request for 10% free customization on this report.
Fujirebio Diagnostics Inc., Cepheid, Diasorin, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Scienion AG, Grifols, Qiagen, Eiken Chemical Co Ltd, Sequenom, bioMerieux SA, Siemens AG, Hologic Inc., Diamedix Inc., Leica Biosystems Nussloch GmbH, F. Hoffmann-La Roche Ltd, Abbott, GSK Biologicals, Roche, and Affymetrix are among the leading players operating in the global virology and bacteriology market. “North America is forecast to dominate the global virology and bacteriology market though 2025 on account of rapid adoption of advanced diagnostic and testing methods in the region. Furthermore, rising spending on healthcare, presence of advanced clinical laboratories and medical device manufacturing companies and favorable government policies, is also contributing to the growing trend. However, Asia-Pacific is forecast to register highest CAGR over the forecast period, which can be attributed to expanding research and development facilities in the field of diagnostics across the region.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Virology and Bacteriology Market By Technology, By Disease, By End User, By Region, Competition, Forecast & Opportunities, 2025” has evaluated the future growth potential of global virology and bacteriology market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global virology and bacteriology market.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017